Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 3 1

Status

Completed 3

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2Lymphoid 1

Conditions

Lymphoma 10Breast Neoplasms 10Leukemia 9Carcinoma, Ovarian Epithelial 8Ovarian Neoplasms 7Multiple Myeloma 7Prostatic Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neuroblastoma 6Myelodysplastic Syndromes 6Melanoma 6Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Acute 6Leukemia, Lymphocytic, Chronic, B-Cell 6Glioblastoma 6Carcinoma, Non-Small-Cell Lung 6Astrocytoma 6Lymphoma, Follicular 5Lung Neoplasms 5Brain Neoplasms 5Oligodendroglioma 4Neoplasms, Plasma Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Hodgkin Disease 4

Interventions

Zidovudine 6tecogalan 4Vincristine 4Interferon alpha-2 4Doxorubicin 4Bleomycin 4sargramostim 3pomalidomide 2interferon alfa-n1 2liposomal doxorubicin 1Zalcitabine 1Tumor Necrosis Factor-alpha 1Sorafenib 1Pentoxifylline 1O-(Chloroacetylcarbamoyl)fumagillol 1Nivolumab 1Muromonab-CD3 1Methotrexate 1Leucovorin 1Isotretinoin 1Interleukin-4 1Interleukin-2 1Interferon beta-1b 1Etoposide 1Didanosine 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1Cidofovir 14,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Acquired Immunodeficiency Syndrome × sargramostim × Clear all
NCT00000681 2021-11-03

A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
24 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00000689 2021-11-02

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
18 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, Nervous System Neoplasms, HIV Infections

NCT00000694 2021-11-02

A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
18 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡